We developed a new method for introducing drugs into the basal cistern of rabbits. With minimal surgical invasion, we used either the opening of the craniopharyngeal duct to access the chiasmatic cistern or the suture between the basisphenoid and basioccipital bones to access the interpeduncular cistern. With our method, 0.5 ml contrast medium injected into three rabbits was determined roentgenographically to remain in the basal cistern; histologically, all the brain tissue remained intact. Intracisternal injection of 0.5 ml physiological saline into five rabbits had no effect on the cardiovascular system. In 23 rabbits, injection of 0. 
D
rugs have been introduced into the basal cistern of cats, rabbits, and monkeys using transclival 1 -3 or transorbital 4 -6 approaches. However, these methods are excessively invasive, bleeding is often difficult to control, and the cisterns are not always reached. We designed two new approaches to reach the basal cistern, through an opening in the craniopharyngeal duct or through the suture between the basisphenoid and basioccipital bones, with minimal surgical injury. Intracisternal injection of 0.5 ml 0.1% prostaglandin F 2a (PGFzJ produced severe electrocardiographic (ECG) changes resembling those seen in patients with subarachnoid hemorrhage.
Materials and Methods
We anesthetized 48 domestic rabbits weighing 2.0-2.5 kg with ether and placed a venous line in an ear vessel. Each rabbit was fixed supine, a tracheostomy was performed, and ventilation through the tracheostomy tube was maintained with a Harvard small animal respirator (South Natick, Massachusetts). During surgery each rabbit was anesthetized with ether and immobilized with pancuronium bro-mide. Arterial blood pressure was measured in the femoral artery using a Teflon catheter and a Statham transducer (Gould, Oxnard, California). The retropharyngeal mucous membrane was ablated rostrally until the suture between the basisphenoid and basioccipital bones was visible ( Figure 1 ); in rabbits weighing 2.0-2.5 kg, this suture is a synchondrosis. Through this suture a needle can be inserted vertically, and at a depth of 8 mm from the ventral surface of the bones the needle reaches the interpeduncular cistern. The orifice of the craniopharyngeal duct lies 6 mm rostral to this suture. A needle can be inserted at an angle of 45° from the ventral surface of the basisphenoid bone, and at a depth of 6 mm the needle reaches the chiasmatic cistern.
In 15 rabbits, 1.0 or 0.5 ml physiological saline was injected into the chiasmatic cistern. After withdrawal of approximately 0.3 ml cerebrospinal fluid (CSF), 0.3 or 0.5 ml 0.1% PGF^ was injected into the chiasmatic cistern of 24 rabbits. In 19 other rabbits, 0.3 or 0.5 ml 0.1% or 0.01% PGF^ was injected into the interpeduncular cistern. Five rabbits anesthetized with ether were placed in the prone position, and a longitudinal skin incision was made along the upper thoracic columns. The fifth to the seventh spinous processes were exposed and removed, and the ligamentum flavum between these vertebrae was exposed. At the level of the fifth or sixth vertebra, a needle was inserted through the ligamentum flavum into the thoracic subarachnoid space. After con- firming that the CSF could be aspirated, 0.3 ml 0.1% PGF^ was injected into the thoracic subarachnoid space. In five rabbits, 0.5 ml 0.1% PGF^ was injected into the venous line in the ear. A few rabbits were placed supine with their heads fixed so that the ventral surface of the basisphenoid bone was practically horizontal, and amidotrizoate meglumine, a radiopaque medium, was injected into the chiasmatic cistern (Figure 2 ) or the interpeduncular cistern. Roentgenograms showed that when 1.0 ml contrast medium was injected it entered the cervical subarachnoid space; however, when 0.5 ml was used, the contrast medium remained in the region of the basal cistern.
Each rabbit was then killed; the skull was removed and placed in 10% buffered formalin for several days, decalcified, sectioned, and stained with hematoxylin and eosin. With either approach (through the craniopharyngeal duct into the chiasmatic cistern [ Figure 3 ] or through the suture between the basisphenoid and basioccipital bones into the interpeduncular cistern [ Figure 4 ]) microscopy showed slight hemorrhage at the injection site and in the subarachnoid space. The brain tissue, including the pituitary gland, was intact.
The data are presented as mean±SD. We compared groups of five rabbits each before injection of 1.0 or 0.5 ml physiological saline using analysis of variance; within each group the significance of changes in physiological parameters were evaluated using Student's t test for paired samples, and between groups Student's / test for unpaired samples was used to compare postinjection values. We compared rates of occurrence of ECG changes produced by injections of two volumes of two concentrations of PGF^ into four sites between groups using the x 2 t e s t -Ah 1 differences were considered significant when p<0.05.
Results
In 10 rabbits, hematocrit was measured by the centrifuge method. The hematocrits before surgery and immediately after injection of physiological saline into the basal cistern were 33.2±0.2% and 31.4±0.4% for chiasmatic and interpeduncular cistern injections, respectively. Table 1 shows that injection of 1.0 ml physiological saline into the chiasmatic cistern significantly elevated systolic and diastolic blood pressure after 5-15 minutes, whereas injection of 0.5 ml physiological saline produced no change except at 5 minutes; heart rate remained unchanged. pH, Pacc>2, PaO2, base excess, total protein, and serum Na + and K + concentrations remained unchanged when 0.5 ml physiological saline was injected into the chiasmatic cistern.
As shown in Table 2 , intracisternal injection of 0.5 ml 0.1% PGF 2o induced ECG changes in 90-100% of the rabbits (Groups V and II), while 0.3 ml 0.1% PGF 2a induced ECG changes in 50-60% (Groups III and VI); the difference between volumes injected into the chiasmatic cistern (Groups II and III) was significant. Intracisternal injection of 0.3 ml 0.01% PGF^ (Group VII) produced no ECG changes. After the C,_ 2 had been dissected (Group IV), injection of 0.5 ml 0.1% PGF 2a into the chiasmatic cistern produced no ECG changes. Injection of 0.3 ml 0.1% PGF 2a into the thoracic subarachnoid space produced no ECG changes in any rabbit (Group VIII). Intravenous injection of 0.5 ml 0.1% PGF 2a did not cause any ECG changes (Group IX), and the degree of bradycardia was slight. The wide variety of ECG changes produced by intracisternal injection of 0.5 ml 0.1% PGF^ are shown in Table 3 . In 10 of 23 rabbits (43.5%), sinus bradycardia occurred, but blood pressure did not change. The time to onset of bradycardia was 38.6±22.9 seconds; after between 20 seconds and 4 minutes 40 seconds, atrial or ventricular premature contractions appeared ( Figure 5 ). These arrhythmias were (in 15 severe cases) followed by T wave inversion, ST elevation, or ventricular tachycardia. In one rabbit, ventricular fibrillation occurred, followed by cardiac arrest.
Intracisternal injection of 0.5 ml 1.0% lidocaine was very effective in correcting the ECG changes caused by intracisternal injection of PGF^. Five to eighty seconds (mean±SD 28.7±29.4 seconds) after the injection of lidocaine, the bradycardia or arrhythmias disappeared, and thereafter the changes in ST and T waves gradually reverted to normal ( Figure 6 ). Discussion ECG changes commonly seen in patients with acute subarachnoid hemorrhage usually mean impending heart damage, especially myocardial infarction.
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8 Since the reports of Burch et al 9 and Connor, 10 a number of studies on ECG abnormalities have appeared. Nevertheless, effective treatment to improve the ECG changes has not been established. Elucidation of the mechanism of ECG Our first objective was to investigate a less invasive and more accurate method of introducing drugs into the basal cisterns of rabbits. In species such as cats or rabbits, the basal cisterns are very small. In rabbits, the distance between each side of the clinoid process of the basisphenoid bone is only 2.0 mm. In addition, the cisterns are surrounded by rich vessels, and an inappropriate approach can lead to bleeding. A transclival approach is even more invasive. In contrast, our method is accurate and less invasive. One drawback in treating the median vertebral vein is that it easily ruptures and bleeds. We found that by injecting a small amount of Biobond (0.07 g cyanoacrylate monomer, 0.07 g nitrile rubber, and 0.01 g toluene diisocyanate in 1 ml) into the vessel, the problem could be overcome with no untoward effect on the cardiovascular system.
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Our second aim was to select a drug that, when introduced into the basal cistern, would produce Intracisternal injection of 0.3 or 0.5 ml 1.0% PGFl ed to a wide variety of ECG changes similar to those seen in patients with subarachnoid hemorrhage. 1 ' Our results suggest that these ECG changes were not due to an absorption of the drug into the circulation or to a direct stimulatory effect on the thoracic subarachnoid sympathetic nerves.
The mechanism of ECG changes is considered to relate to a massive release of catecholamine, stimulation of the sympathoadrenal system 1415 or the sympathetic cardiac nerve, 16 or stimulation of the hypothalamus due to cerebral vasospasm.
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- 19 Locally applied PGF^ produces cerebral vasospasm, 20 -22 but further studies on the mechanism of ECG changes produced by intracisternal injection of PGFâ re required. Intracisternal injection of 1.0% lidocaine immediately abolished the ECG changes produced by intracisternal injection of PGF^. However, the mechanism of this antiarrhythmic effect was not clear.
We conclude that the clinical features of ECG changes seen in patients with subarachnoid hemorrhage are reproducible in this animal model and that therapeutic aspects of drug administration may be tested using this method.
